Influx Healthtech Limited
- Minimum Investment₹1,09,200
- Price Range₹91 - ₹96
- Issue Size₹58.57 Cr
- Lot Size1200 shares
This stock belongs to the SME (Small & Medium Enterprises) segment which usually has low liquidity and hence, is also riskier. It will be traded in a lot size of 2000 shares after listing.
Proceeds of this IPO to be used for
Funding capital expenditure requirements to set up a manufacturing facility for the Nutraceutical Division
Funding capital expenditure requirements to set up a manufacturing facility for the Veterinary Food Division
Purchase of machinery for Homecare & Cosmetic Division
General corporate purposes
Strengths & Weaknesses of Influx Healthtech Limited
Diversified product portfolio
The company specialises in contract manufacturing a diverse range of products, including multi-nutritional tablets, dietary supplements, Ayurvedic products, oral dispersible films, gummies, and ice sticks. Its broad portfolio reflects its adaptability, innovation, and commitment to meeting varied customer needs across market segments
Quality assurance & control
The company maintains strict quality control at every stage of manufacturing to ensure its products meet customer requirements and pass all validations. This commitment to quality ensures consistent excellence across its offerings
Formulation development
The company’s Formulation Development Department drives innovation by creating market-ready solutions for third-party clients, ensuring products meet both consumer needs and regulatory standards
Cost overruns
The company has yet to place orders for machinery/equipment for its proposed expansion. Any delays or vendor issues may lead to time and cost overruns
Price fluctuation risks
The company depends on third-party suppliers for raw materials, mostly sourced from the spot market without long-term contracts, exposing it to price volatility and supply risks. Inability to pass on cost increases or secure timely, quality supplies may impact margins, cause production delays, and affect revenue and customer retention
Counterfiet risks
The company faces the risk of counterfeit or look-alike products being sold under its brand by entities in India and abroad. Such imitation can harm its goodwill and reduce market share by diverting demand away from genuine products
Financials
Earnings Per Share
No Data
Balance Sheet
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Total Current Assets | -- | |
Total Non-Current Assets | -- | |
Fixed assets | -- | |
Total assets | -- | |
Total Current Liabilities | -- | |
Total Non-Current Liabilities | -- | |
Total Capital Plus Liabilities | -- | |
Total Shareholder Funds | -- | |
Total Debt to Equity | -- |
Cash Flow
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Cash from Operating Activity | -- | |
Cash from Financing Activities | -- | |
Cash from Investing Activities | -- | |
Net Cash Flow | -- |
About Influx Healthtech Limited
- PromoterMunir Abdul Ganee Chandniwala
- PromoterShirin Munir Ahmed Chandniwala
- PromoterAbdul Ganee Abdul Rasul Chandniwala